Table I.
Gene symbol | Forward | Reverse |
---|---|---|
CDKN1A (p21Cipl) | GACTCTCAGGGTCGAAAAACG | GGATTAGGGCTTCCTCTTGG |
VEGF | CAGAAGGAGGAGGGCAGAA | CTCGATTGGAGGCAGTAGC |
HIF1 | CCGCTGGAGACACAATCATA | CTTCCTCAAGTTGCTTTTCA |
HGF | ATTTGGCCATGTTTTGACC | AGCTGCGTCCTTTACCAATG |
CD133 | GCTTTGCAATCTCCCTGTTG | AGCTGCGTCCTTTACCAATG |
SOX2 | CAAGATGCACAACTCGGAGA | GCTTAGCCTCGTCGATGAAC |
OcT4 | CTGGAGAAGGAGAAGCTGGA | CAAATTGCTCGAGTTCTTTCTG |
BAX | CTTTGCCAGCAAACTGGTG | CAGCCCATGATGGTTCTGA |
BCL2 | TCGCCCTGTGGATGACTGA | CAGACAGAGCCAGGTTCTGA |
CXCL12 | ATGAACGCCAAGGTCGTG | ACATGGCTTTCGAAGAATCG |
CXCR4 | CAGCAGGTAGCAAAGTGACG | ATAGTCCCCTGACCCTTT |
ACTB | ACAGAGCCTCGCCTTTGC | GCGGCGATATCATCATC |
CDKN1A (p21Cipl), cyclin-dependent kinase inhibitor 1A; VEGF, vascular endothelial growth factor; HIF1, hypoxia-inducible factor 1; HGF, hepatocyte growth factor; SOX2, sex-determining region Y-box 2; OCT4, octamer-binding transcription factor; BAX, BCL2-associated X protein; BCL2, B-cell lymphoma 2; CXCL12, C-X-C motif chemokine 12; CXCR4, C-X-C chemokine receptor type 4; ACTB, β-actin.